Jeffrey B. Mirviss - 14 Feb 2024 Form 4 Insider Report for BOSTON SCIENTIFIC CORP (BSX)

Role: EVP&Pres, Periph Intervent
Signature: /s/ Susan Thompson, Attorney-in-Fact
Issuer symbol: BSX
Transactions as of: 14 Feb 2024
Net transactions value: -$83,493
Form type: 4
Filing time: 16 Feb 2024, 16:22:07 UTC
Previous filing: 14 Feb 2024
Next filing: 20 Feb 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BSX	Common Stock	Options Exercise	$0	+2,776	+3.9%	$0.000000	73,870	14 Feb 2024	Direct	F1
transaction	BSX	Common Stock	Tax liability	$83,493	-1,266	-1.7%	$65.95	72,604	14 Feb 2024	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BSX	Restricted Stock Units	Options Exercise	$0	-2,776	-25%	$0.000000	8,328	14 Feb 2024	Common Stock	2,776		Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
F2	Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 14, 2024, the first anniversary of the date of grant.